Disclaimer: All products are for laboratory research only and not for human or animal use or consumption. For in-vitro research by qualified professionals only

Disclaimer: All products are for laboratory research only and not for human or animal use or consumption. For in-vitro research by qualified professionals only

SS-31 (Elamipretide)

$141.90

Full Name: Elamipretide
Alternative Names: SS-31, MTP-131, Bendavia
CAS #: 736992-21-5
Molecular Formula: C₃₂H₄₉N₉O₅
Molecular Weight (M.W.): 639.8 g/mol
Sequence / Structural Representation: H-D-Arg-2,6-dimethyl-Tyr-Lys-Phe-NH₂
Sequence Code: RXKF
Product Type: Modified Synthetic Research Tetrapeptide

VIEW COA

Description

SS-31, also known as Elamipretide, is a synthetic modified tetrapeptide supplied for controlled laboratory and analytical research. Its structure contains D-arginine, a modified dimethyltyrosine residue, lysine, and C-terminally amidated phenylalanine.

These structural features distinguish SS-31 from conventional peptides composed exclusively of standard unmodified amino acids. Its defined molecular architecture supports scientific work involving peptide characterization, molecular interactions, mitochondrial-associated biochemical systems, and analytical research.

Verify the exact chemical form, salt state, purity specification, and lot-specific analytical identity using the applicable Certificate of Analysis.

Research Applications

SS-31 may be examined in controlled non-clinical research involving:

  • Modified peptide characterization
  • Mitochondrial-associated biochemical studies
  • Molecular interaction research
  • Membrane-associated experimental systems
  • Structure-function analysis
  • Analytical peptide comparison
  • Stability and structural investigations
  • Non-clinical cellular models

Any experimental observations should remain specific to the study design and should not be interpreted as evidence of therapeutic efficacy, clinical benefit, or suitability for human use.

Structural Information

SS-31 is commonly represented as:

H-D-Arg-2,6-dimethyl-Tyr-Lys-Phe-NH₂

The structure contains a D-configured arginine residue, a chemically modified tyrosine residue, and a C-terminal amide. These characteristics are important for accurate analytical identification.

Analytical Identification

Relevant characterization may include:

  • Compound identity confirmation
  • Molecular mass assessment
  • Modified-residue verification
  • Chromatographic purity testing
  • Structural characterization
  • Lot-specific analytical testing

SS-31 may also be supplied as a TFA or other salt form, in which case the reported molecular formula and molecular weight will differ from the free form.

Specifications & Documentation

Lot-specific documentation should be reviewed for:

  • Material identity
  • Structural representation
  • Molecular formula
  • Molecular weight
  • Salt or counter-ion form
  • Purity specification
  • Analytical testing
  • Lot or batch information
  • Certificate of Analysis
  • Storage requirements

Authenticated product-specific documentation should take precedence over generalized reference values.

Storage & Handling

Store according to the conditions stated on the product label and Certificate of Analysis. Protect the material from environmental factors that could affect peptide integrity.

Follow established laboratory procedures appropriate for research materials.

Research Use Only

SS-31 is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.

Disclaimer

For research use only. Not for human or veterinary use. Not intended for consumption, administration, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, mitochondrial, medical, or clinical claims are made or implied. All information is provided solely for scientific identification, documentation, and research reference.

Additional information

dose

10mg

Reviews

There are no reviews yet.

Be the first to review “SS-31 (Elamipretide)”

Your email address will not be published. Required fields are marked *